Notably, the effect of the NNMT inhibitor NNMTi was investigated in two ccRCC cell lines (786‐O and A498), two patient‐derived 2D models (RCC1 and RCC2) and three ex vivo patient‐derived 3D ALI ccRCC models. This evidence concerns the gene NNMT and nonpapillary renal cell carcinoma.